Havrix 58160-0826
Generic: Hepatitis A Vaccine
Product NDC
58160-0826- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- April 13, 2007
- Listing Expires
- December 31, 2027
- Application
- BLA103475
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hepatitis A Virus Strain Hm175 Antigen (formaldehyde Inactivated) | 1440 [iU]/mL |
Drug Class
Actively Acquired Immunity [PE]Hepatitis A Vaccines [CS]Inactivated Hepatitis A Virus Vaccine [EPC]
Packaging Options(1)
10 SYRINGE in 1 CARTON (58160-826-52) / 1 mL in 1 SYRINGE (58160-826-43)